The rapid proliferation of compounded versions of high-demand GLP-1 receptor agonists has reached a critical inflection point, as the U.S.…
Read More
FDA logs more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide
The regulatory landscape surrounding the booming market for compounded GLP-1 weight-loss medications has reached a critical inflection point, as the…
Read More
Unlocking the Cosmos: LUX-ZEPLIN Experiment Reports Most Compelling Dark Matter Signal to Date
For nearly a century, the composition of the universe has remained one of modern physics’ most enduring and profound mysteries.…
Read More
AMSBIO Reports Karolinska Institutet’s Groundbreaking Research Using AAV Products to Uncover Neural Basis of Rheumatoid Arthritis Pain
AMSBIO, a leading provider of life science reagents and services, has announced its involvement in a pivotal research endeavor by…
Read More
Dr. Marty Makary Resigns as FDA Commissioner Amidst Reports of Presidential Discontent
Dr. Marty Makary has formally resigned from his position as Commissioner of the U.S. Food and Drug Administration (FDA), a…
Read More
Gilead Sciences Reports Robust Q1 2026 Performance Driven by Strong HIV Portfolio and Promising PrEP Launches
Gilead Sciences has commenced 2026 with a demonstrably strong first quarter, reporting significant revenue growth primarily fueled by its leading…
Read MoreYOU MAY HAVE MISSED
